Panretinal laser photocoagulation

PROCEDURE2 trials

Sponsors

Novartis Pharmaceuticals, Odense University Hospital

Conditions

Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy (PDR)

Phase 2

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

CompletedNCT01594281

Novartis PharmaceuticalsProliferative Diabetic Retinopathy (PDR)

Start: 2012-12-11End: 2017-12-05Updated: 2019-03-15

Phase 3

The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT

CompletedNCT02157350

Odense University HospitalProliferative Diabetic Retinopathy

Start: 2014-08-31End: 2017-09-30Updated: 2019-01-25